METEOROID Clinical Trial of Enspryng (Satralizumab) in Patients With MOGAD by Madaline Spencer| Published on: Jun 4, 2026

METEOROID Clinical Trial of Enspryng (Satralizumab) in Patients With MOGAD by Madaline Spencer| Published on: Jun 4, 2026 Michael Levy, MD, PhD, Neuroimmunologist and Associate Professor at Harvard Medical School, discusses results from the METEOROID clinical trial of Enspryng (satralizumab) in patients with myelin oligodendrocyte glycoprotein antibody-associated disease (MOGAD). https://checkrare.com/meteoroid-clinical-trial-of-enspryng-satralizumab-in-patients-with-mogad/